MULTIDRUG-RESISTANT TUBERCULOSIS

Clinical trials for MULTIDRUG-RESISTANT TUBERCULOSIS explained in plain language.

Never miss a new study

Get alerted when new MULTIDRUG-RESISTANT TUBERCULOSIS trials appear

Sign up with your email to follow new studies for MULTIDRUG-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for kids battling untreatable TB

Disease control Recruiting now

This study aims to see if a drug called bedaquiline is safe and works well for children and teenagers with a hard-to-treat form of tuberculosis (MDR-TB). Researchers will give bedaquiline along with other standard TB drugs to up to 60 participants, from newborns to under 18 years…

Matched conditions: MULTIDRUG-RESISTANT TUBERCULOSIS

Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

MULTIDRUG-RESISTANT TUBERCULOSIS

Get alerted when new MULTIDRUG-RESISTANT TUBERCULOSIS trials appear

New hope for kids battling untreatable TB